Tuesday, 28 January 2020

Generics News

  • Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2016

    Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided with antiviral Dual Protect VivaGel condoms for the upcoming Olympic ...Read more

  • Celgene settles litigation with India's Natco

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2015

    Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow International and Arrow's parent company, Watson Laboratories relating to patents...Read more

  • Self monitoring diabetes market to reach $358 mn

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly 200 million for the self monitoring of blood glucose (SMBG) market. ...Read more

  • Do India's bad quality drugs end up in Africa?

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

    Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from India to Africa are of lower quality, when compared to the same medici...Read more

  • Will Japan be able to reduce its generic drug prices?

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 May, 2013

    The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (...Read more

  • Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

    The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license agreement with Daiichi Sankyo Company Ltd. to develop and commercializ...Read more

  • Mylan signs a settlement agreement with OSI Pharma

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: US generics major Mylan has entered into a settlement agreement with OSI Pharmaceuticals, a subsidiary of Japan's Astellas, Pfizer and Roche subsidiary Genentech that will resolv...Read more

  • India bans pain killer 36 years after the US did so

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

    New Delhi: The Indian health ministry has banned the sale of three medicines after learning about the health risks associated with them. Manufacture and sale of three drugs, painkiller Ana...Read more

  • Beximco Pharma enters EU market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: Beximco Pharmaceuticals, a manufacturer of generic pharmaceutical products and active pharmaceutical ingredients in Bangaldesh, has commenced export of its products to Europe. I...Read more

  • Glenmark's new generic gets FDA nod

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2015

    Singapore: Glenmark Pharmaceuticals(Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for Drospirenone and Ethinyl Estradiol Tablets USP...Read more

  • Amneal pharma to acquire Actavis Australia's generic business

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

    Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Australia. The company has inked a binding letter of intent to acquire t...Read more

  • ANI pharma, IDT Australia to commercialize US generic drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

    Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Australia a global generic manufacturer, to commercialize up to 18 previo...Read more

  • Brickell Biotech-Kaken Pharma to co-develop dermatology drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

    Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development agreement for BBI-4000 with Kaken Pharmaceutical Co. Ltd., a top-tier...Read more

  • Lupin scouts for acquisitions across the world

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

    Singapore: Indian drug major Lupin Pharmaceuticals is set to expand its global footprint by scouting for acquisitions across the world. The company is looking at US, Japan, China and even t...Read more

  • US rheumatoid arthritis market to reach $9.3 bn by 2020'

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2015

    Singapore: US treatment market for rheumatoid arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing a compound annual growth rate (CAGR)...Read more

  • BioSpectrum announces the hits and misses of 2013

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2014

    Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase in the number of acquisitions and mergers (M&A), it also led to a ...Read more

  • Teva proposes to buy Mylan for $40.1 billion

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 22 Apr, 2015

    Singapore: Israeli generic drug giant Teva pharmaceuticals made an unsolicited offer to buy US-based Mylan NV for about $40.1 billion, in the drug industry's largest takeover attempt this y...Read more

  • Teva's Potential $40 bn Mylan acquisition could transform generics space'

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 27 Apr, 2015

    Singapore: Teva Pharmaceutical Industries' recent $40.1 billion offer to purchase Netherlands-based Mylan, which is crucially contingent on Mylan not consummating its offer to acquire Irish...Read more



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls